Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027?
One-OffHealth & MedicineWissenschaft1J
Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-Prognose
Nein 76.9%
Prognostiker
7
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 18 Stunden
Veraltet17. Jan. 24, 01:47 UTC1. Jan. 28, 04:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will China have more phase 3 drug trials than the United States in year X?
Manifold MarketsWill BioAge's BGE-102 achieve its primary endpoint in the Phase 2 QUELL-CV trial before January 1, 2028?
Manifold MarketsIf I choose to undergo past life regression therapy, what will I have been?
Manifold MarketsTdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurHow many clinical trials will have started in Prospera by Dec 31, 2026?
FutuurWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiRegeln
Auflösungskriterien sind für diesen Markt noch nicht verfügbar. Dieser Abschnitt wird nach den nächsten Aktualisierungen gefüllt, sobald die Quellregeln gespeichert sind.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 35.620,9 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.9pt3%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5183,7 €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Gesamtvolumen
- 83.504,6 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt96%
- Above 6000-4.0pt58%
+2 weitere Ergebnisse
- Gesamtvolumen
- 864.245,4 €
- 24h-Volumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 915.756,6 €
- 24h-Volumen
- 1507,6 €
KALSHIWhen will the FDA approve Intellia Therapeutics' lonvo-z?
- Before July 2027+67.0pt97%
- Before 202872%
- Before October 202752%
- Gesamtvolumen
- 4192,1 €
- 24h-Volumen
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- When will the FDA reclassify BPC-157 to Category 1?
- Ebola pandemic in 2026?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- Will the FDA approve CagriSema?
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027??
- Manifold Markets bewertet No mit 77% (Stand: 8. September 2026).
- Wann wird Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027? entschieden?
- Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027? soll am 1. Januar 2028 entschieden werden.